This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Jul;86(7):2965-8.

doi: 10.1210/jcem.86.7.7784.

If gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what?

PMID: 11443152
DOI: 10.1210/jcem.86.7.7784

Editorial

If gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what?

P B Kaplowitz. J Clin Endocrinol Metab. 2001 Jul.

. 2001 Jul;86(7):2965-8.

doi: 10.1210/jcem.86.7.7784.

Author

PMID: 11443152
DOI: 10.1210/jcem.86.7.7784

No abstract available

PubMed Disclaimer

Comment on

A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM. Kamp GA, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):2969-75. doi: 10.1210/jcem.86.7.7650. J Clin Endocrinol Metab. 2001. PMID: 11443153 Clinical Trial.

Similar articles

Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ, van der Kaay DC, Hokken-Koelega AC. Lem AJ, et al. J Clin Endocrinol Metab. 2013 Jan;98(1):77-86. doi: 10.1210/jc.2012-2492. Epub 2012 Nov 2. J Clin Endocrinol Metab. 2013. PMID: 23125290 Clinical Trial.
Use of GnRH agonists in GH-deficient patients: arguments for and against. The case against GnRH agonists in GH-deficient patients.
Rose SR. Rose SR. Pediatr Endocrinol Rev. 2008 Feb;5 Suppl 2:744, 750-4. Pediatr Endocrinol Rev. 2008. PMID: 18317447 No abstract available.
Use of GnRH agonists in GH-deficient patients: arguments for and against. The case for GnRH agonists in GH-deficient patients.
Lee PA. Lee PA. Pediatr Endocrinol Rev. 2008 Feb;5 Suppl 2:744-9. Pediatr Endocrinol Rev. 2008. PMID: 18317446
Management of puberty in growth hormone deficient children.
Saggese G, Federico G, Barsanti S. Saggese G, et al. J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:329-34. J Pediatr Endocrinol Metab. 1999. PMID: 10698597 Review.
Benefit of postponing normal puberty for improving final height.
Wit JM, Balen HV, Kamp GA, Oostdijk W. Wit JM, et al. Eur J Endocrinol. 2004 Aug;151 Suppl 1:S41-5. doi: 10.1530/eje.0.151s041. Eur J Endocrinol. 2004. PMID: 15339243 Review.

See all similar articles

Cited by

Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.
Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, Ito Y, Shigesada K. Yoshida T, et al. Am J Hum Genet. 2002 Oct;71(4):724-38. doi: 10.1086/342717. Epub 2002 Aug 26. Am J Hum Genet. 2002. PMID: 12196916 Free PMC article.
Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
Karamizadeh Z, Kashef MA, Jalaeian H, Namazee N. Karamizadeh Z, et al. Kaohsiung J Med Sci. 2006 Apr;22(4):161-5. doi: 10.1016/S1607-551X(09)70301-8. Kaohsiung J Med Sci. 2006. PMID: 16679296 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems